+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug Eluting Device Market: Market Size, Trends, Opportunities and Forecast by Application, Product Type, Coating Type, Region, By Country: 2020-2030- Product Image
Drug Eluting Device Market: Market Size, Trends, Opportunities and Forecast by Application, Product Type, Coating Type, Region, By Country: 2020-2030- Product Image
New

Drug Eluting Device Market: Market Size, Trends, Opportunities and Forecast by Application, Product Type, Coating Type, Region, By Country: 2020-2030

  • PDF Icon

    Report

  • 256 Pages
  • October 2024
  • Region: Global
  • Azoth Analytics
  • ID: 6020264
Description Jump to:
This report highlights different factors and opportunities prevailing in the “Global Drug Eluting Device Market (2024 Edition)”. According to the report, the Global Drug Eluting Device Market was valued at USD 6.58 billion and is expected to grow at a CAGR of 6% during 2025-2030.

The report explores a multi-faceted opportunity landscape in terms of market segmentation by Application (Cardiovascular Diseases, Peripheral Vascular Diseases, Oncology, Ophthalmology and Other Applications), By Product Type (Coronary Drug Eluting Stents, Peripheral Drug Eluting Stents, Drug Eluting Balloons and Drug Eluting Implants) and By Coating Type (Polymer Based and Non-Polymer Based).

Market Overview

The Drug Eluting Device Market is growing rapidly, fueled by the increasing prevalence of chronic diseases, such as cardiovascular diseases, cancer, and diabetes, which require long-term treatment and drug delivery solutions. Drug eluting devices are medical devices that release a therapeutic drug over time, directly at the targeted site, offering a more localized and controlled treatment compared to systemic drug administration. These devices are particularly useful in treating conditions where sustained drug release is necessary, such as in stent implantation for cardiovascular diseases.

One of the primary drivers of the market is the rising incidence of cardiovascular diseases, which has led to an increased demand for drug eluting stents. These stents are used to treat narrowed or blocked arteries by releasing anti-proliferative drugs, reducing the risk of restenosis (re-narrowing of the artery). The growing aging population, coupled with lifestyle-related risk factors such as obesity, smoking, and physical inactivity, has contributed to the rising number of cardiovascular interventions, thus boosting the demand for drug eluting devices.

Moreover, advancements in drug eluting technologies, such as the development of bioresorbable stents and polymer coatings, have improved the efficacy and safety profiles of these devices, further driving market growth. The oncology segment is also experiencing increased demand for drug eluting devices, as they provide targeted and localized drug delivery for cancer treatment, minimizing the side effects associated with chemotherapy. The ongoing innovation in material science and drug formulations is expected to open new avenues for the market in the coming years.

Segment Insights

The cardiovascular segment holds the largest share of the Drug Eluting Device Market, accounting for around 60% of the market in 2023. The increasing use of drug eluting stents in treating coronary artery diseases is a key driver of this segment. The oncology segment is also growing, driven by the need for localized drug delivery in cancer treatment.

Geographical Insights

The Americas lead the Drug Eluting Device Market, with the U.S. being a major contributor due to its advanced healthcare infrastructure, high prevalence of cardiovascular diseases, and strong focus on medical innovation. Europe and the Asia-Pacific region are also significant markets, with increasing healthcare expenditure and rising demand for advanced medical devices.

Market Segmentation

By Application:

  • Cardiovascular Diseases
  • Peripheral Vascular Diseases
  • Oncology
  • Ophthalmology
  • Other Applications

By Product Type:

  • Coronary Drug Eluting Stents
  • Peripheral Drug Eluting Stents
  • Drug Eluting Balloons
  • Drug Eluting Implants

By Coating Type:

  • Polymer Based
  • Non-Polymer Based

By Geography:

  • Americas (The United States, Canada, Brazil, Mexico, Rest of Americas)
  • Europe (United Kingdom, Germany, France, Italy, Spain, Turkey, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, South Korea, India, Singapore, Indonesia, Rest of Asia Pacific)
  • Middle East and Africa (GCC, Israel, South Africa, Rest of Middle East and Africa)

Key Companies

The report assesses the competitive developments, strategies, mergers and acquisitions and new product development and market share portfolio of top 15 companies.

Key companies in the Global Drug Eluting Device Market include:

  • Terumo
  • Becton, Dickinson and Company
  • Orbus Neich
  • Biotronik SE
  • Philips Group
  • Medtronic Plc
  • Lepu Medical
  • Abbott Laboratories
  • Cordis Corp
  • Boston Scientific Group

Reasons to buy this report:

  • In-Depth Comparative Assessment of Top 20 Markets in the Drug Eluting Device Market Product Type: Comparative assessment of 20 leading countries highlighting the total addressable market, opportunities, lucrative segments and competitive positioning of leading companies.
  • Comprehensive Historical, Present, and Future Analytics of the Drug Eluting Device Market: A deep dive in the historical (2020-2023), current (2024) and forecast (2025-2030) market analytics of Drug Eluting Device Market.
  • Detailed Analysis of Drug Eluting Device Market By Application, Product Type, and Coating Type Across 20 Countries
  • Beyond the Purchase: 90 Days of Support
  • Direct Access to Analysts: Have questions after reading the report? Our expert analysts are just a call or email away.
  • Customized Assistance: Whether you're integrating insights into your strategy or have questions about market dynamics, our team provides tailored support to meet your specific business needs.
  • Data Customization Requests: During the support period, you have the flexibility to request additional data cuts or deeper dives into specific areas of interest.
  • Gain insights specific to new entrants or new market areas to tap: The study provides detailed market entry strategies, including analysis of barriers to entry, pricing strategies, opportunities, trends, drivers, and challenges and product positioning using the Opportunity Portfolio Matrix (OPM)
  • Strategic Product Type Movements: Tracking Competitive Developments and Key Players in the Market: The report covers competitive strategies, mergers & acquisitions, new developments, future plans and market share analysis of ~15 top companies.


This product will be delivered within 2 business days.

Table of Contents

1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology
2. Analyst Recommendations
3. Global Drug Eluting Device Market: Historic and Forecast
3.1 Impact Analysis of Macro Economic Factors on Global Drug Eluting Device Market
3.2 Drug Eluting Device Market Type Matrix
3.3 Global Drug Eluting Device Market: Dashboard
3.4 Global Drug Eluting Device Market: Market Size and CAGR, By Value, 2020-2030 (USD Million & CAGR)
3.5 Global Drug Eluting Device Market: Market Value Assessment
3.6 Assessment Degree of Impact of COVID-19 on Global Drug Eluting Device Market
3.7 Global Drug Eluting Device Market Segmentation: By Application
3.7.1 Global Drug Eluting Device Market, By Application Overview
3.7.2 Global Drug Eluting Device Market Attractiveness Index, By Application (2025-2030)
3.7.3 Global Drug Eluting Device Market Size, By Cardiovascular Diseases, By Value, 2020H-2030F (USD Million & CAGR)
3.7.4 Global Drug Eluting Device Market Size, By Peripheral Vascular Diseases, By Value, 2020H-2030F (USD Million & CAGR)
3.7.5 Global Drug Eluting Device Market Size, By Oncology, By Value, 2020H-2030F (USD Million & CAGR)
3.7.6 Global Drug Eluting Device Market Size, By Ophthalmology, By Value, 2020H-2030F (USD Million & CAGR)
3.7.7 Global Drug Eluting Device Market Size, By Other Applications, By Value, 2020H-2030F (USD Million & CAGR)
3.8 Global Drug Eluting Device Market Segmentation: By Product Type
3.8.1 Global Drug Eluting Device Market, By Product Type Overview
3.8.2 Global Drug Eluting Device Market Attractiveness Index, By Product Type (2025-2030)
3.8.3 Global Drug Eluting Device Market Size, By Coronary Drug Eluting Stents , By Value, 2020H-2030F (USD Million & CAGR)
3.8.4 Global Drug Eluting Device Market Size, By Peripheral Drug Eluting Stents, By Value, 2020H-2030F (USD Million & CAGR)
3.8.5 Global Drug Eluting Device Market Size, By Drug Eluting Balloons, By Value, 2020H-2030F (USD Million & CAGR)
3.8.6 Global Drug Eluting Device Market Size, By Drug Eluting Implants, By Value, 2020H-2030F (USD Million & CAGR)
3.9 Global Drug Eluting Device Market Segmentation: By Coating Type
3.9.1 Global Drug Eluting Device Market, By Coating Type Overview
3.9.2 Global Drug Eluting Device Market Attractiveness Index, By Coating Type (2025-2030)
3.9.3 Global Drug Eluting Device Market Size, By Polymer Based , By Value, 2020H-2030F (USD Million & CAGR)
3.9.4 Global Drug Eluting Device Market Size, By Non-Polymer Based, By Value, 2020H-2030F (USD Million & CAGR)
4. Drug Eluting Device Market, Region Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot
5. Americas Drug Eluting Device Market: Historic and Forecast
5.1 Americas Drug Eluting Device Market: Snapshot
5.2 Americas Drug Eluting Device Market: Market Size and CAGR, By Value, 2020-2030 (USD Million & CAGR)
5.3 Americas Drug Eluting Device Market: Key Factors
5.4 Americas Drug Eluting Device Market: Segment Analysis
5.5 Americas Drug Eluting Device Market Segmentation: By Application
5.5.1 Americas Drug Eluting Device Market, By Application Overview
5.5.2 Americas Drug Eluting Device Market Size, By Cardiovascular Diseases, By Value, 2020H-2030F (USD Million & CAGR)
5.5.3 Americas Drug Eluting Device Market Size, By Peripheral Vascular Diseases, By Value, 2020H-2030F (USD Million & CAGR)
5.5.4 Americas Drug Eluting Device Market Size, By Oncology, By Value, 2020H-2030F (USD Million & CAGR)
5.5.5 Americas Drug Eluting Device Market Size, By Ophthalmology, By Value, 2020H-2030F (USD Million & CAGR)
5.5.6 Americas Drug Eluting Device Market Size, By Other Applications, By Value, 2020H-2030F (USD Million & CAGR)
5.6 Americas Drug Eluting Device Market Segmentation: By Product Type
5.6.1 Americas Drug Eluting Device Market, By Product Type Overview
5.6.2 Americas Drug Eluting Device Market Size, By Coronary Drug Eluting Stents , By Value, 2020H-2030F (USD Million & CAGR)
5.6.3 Americas Drug Eluting Device Market Size, By Peripheral Drug Eluting Stents, By Value, 2020H-2030F (USD Million & CAGR)
5.6.4 Americas Drug Eluting Device Market Size, By Drug Eluting Balloons, By Value, 2020H-2030F (USD Million & CAGR)
5.6.5 Americas Drug Eluting Device Market Size, By Drug Eluting Implants, By Value, 2020H-2030F (USD Million & CAGR)
5.7 Americas Drug Eluting Device Market Segmentation: By Coating Type
5.7.1 Americas Drug Eluting Device Market, By Coating Type Overview
5.7.2 Americas Drug Eluting Device Market Size, By Polymer Based , By Value, 2020H-2030F (USD Million & CAGR)
5.7.3 Americas Drug Eluting Device Market Size, By Non-Polymer Based, By Value, 2020H-2030F (USD Million & CAGR)
5.8 Americas Drug Eluting Device Market Segmentation: By Country
5.8.1 Americas Drug Eluting Device Market, by Country Overview
5.8.2 United States Drug Eluting Device Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.2.1 United States Drug Eluting Device Market, By Application
5.8.2.2 United States Drug Eluting Device Market, By Product Type
5.8.2.3 United States Drug Eluting Device Market, By Coating Type
5.8.3 Canada Drug Eluting Device Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.3.1 Canada Drug Eluting Device Market, By Application
5.8.3.2 Canada Drug Eluting Device Market, By Product Type
5.8.3.3 Canada Drug Eluting Device Market, By Coating Type
5.8.4 Brazil Drug Eluting Device Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.4.1 Brazil Drug Eluting Device Market, By Application
5.8.4.2 Brazil Drug Eluting Device Market, By Product Type
5.8.4.3 Brazil Drug Eluting Device Market, By Coating Type
5.8.5 Mexico Drug Eluting Device Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.5.1 Mexico Drug Eluting Device Market, By Application
5.8.5.2 Mexico Drug Eluting Device Market, By Product Type
5.8.5.3 Mexico Drug Eluting Device Market, By Coating Type
5.8.6 Rest of Americas Drug Eluting Device Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.6.1 Rest of Americas Drug Eluting Device Market, By Application
5.8.6.2 Rest of Americas Drug Eluting Device Market, By Product Type
5.8.6.3 Rest of Americas Drug Eluting Device Market, By Coating Type
6. Europe Drug Eluting Device Market: Historic and Forecast
6.1 Europe Drug Eluting Device Market: Snapshot
6.2 Europe Drug Eluting Device Market: Market Size and CAGR, BY Value, 2020-2030 (USD Million & CAGR)
6.3 Europe Drug Eluting Device Market: Key Factors
6.4 Europe Drug Eluting Device Market: Segment Analysis
6.5 Europe Drug Eluting Device Market Segmentation: By Application
6.5.1 Europe Drug Eluting Device Market, By Application Overview
6.5.2 Europe Drug Eluting Device Market Size, By Cardiovascular Diseases, By Value, 2020H-2030F (USD Million & CAGR)
6.5.3 Europe Drug Eluting Device Market Size, By Peripheral Vascular Diseases, By Value, 2020H-2030F (USD Million & CAGR)
6.5.4 Europe Drug Eluting Device Market Size, By Oncology, By Value, 2020H-2030F (USD Million & CAGR)
6.5.5 Europe Drug Eluting Device Market Size, By Ophthalmology, By Value, 2020H-2030F (USD Million & CAGR)
6.5.6 Europe Drug Eluting Device Market Size, By Other Applications, By Value, 2020H-2030F (USD Million & CAGR)
6.6 Europe Drug Eluting Device Market Segmentation: By Product Type
6.6.1 Europe Drug Eluting Device Market, By Product Type Overview
6.6.2 Europe Drug Eluting Device Market Size, By Coronary Drug Eluting Stents , By Value, 2020H-2030F (USD Million & CAGR)
6.6.3 Europe Drug Eluting Device Market Size, By Peripheral Drug Eluting Stents, By Value, 2020H-2030F (USD Million & CAGR)
6.6.4 Europe Drug Eluting Device Market Size, By Drug Eluting Balloons, By Value, 2020H-2030F (USD Million & CAGR)
6.6.5 Europe Drug Eluting Device Market Size, By Drug Eluting Implants, By Value, 2020H-2030F (USD Million & CAGR)
6.7 Europe Drug Eluting Device Market Segmentation: By Coating Type
6.7.1 Europe Drug Eluting Device Market, By Coating Type Overview
6.7.2 Europe Drug Eluting Device Market Size, By Polymer Based , By Value, 2020H-2030F (USD Million & CAGR)
6.7.3 Europe Drug Eluting Device Market Size, By Non-Polymer Based, By Value, 2020H-2030F (USD Million & CAGR)
6.8 Europe Drug Eluting Device Market Segmentation: By Country
6.8.1 Europe Drug Eluting Device Market, by Country Overview
6.8.2 Russia Drug Eluting Device Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.2.1 Russia Drug Eluting Device Market, By Application
6.8.2.2 Russia Drug Eluting Device Market, By Product Type
6.8.2.3 Russia Drug Eluting Device Market, By Coating Type
6.8.3 France Drug Eluting Device Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.3.1 France Drug Eluting Device Market, By Application
6.8.3.2 France Drug Eluting Device Market, By Product Type
6.8.3.3 France Drug Eluting Device Market, By Coating Type
6.8.4 United Kingdom Drug Eluting Device Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.4.1 United Kingdom Drug Eluting Device Market, By Application
6.8.4.2 United Kingdom Drug Eluting Device Market, By Product Type
6.8.4.3 United Kingdom Drug Eluting Device Market, By Coating Type
6.8.5 Germany Drug Eluting Device Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.5.1 Germany Drug Eluting Device Market, By Application
6.8.5.2 Germany Drug Eluting Device Market, By Product Type
6.8.5.3 Germany Drug Eluting Device Market, By Coating Type
6.8.6 Italy Drug Eluting Device Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.6.1 Italy Drug Eluting Device Market, By Application
6.8.6.2 Italy Drug Eluting Device Market, By Product Type
6.8.6.3 Italy Drug Eluting Device Market, By Coating Type
6.8.7 Spain Drug Eluting Device Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.7.1 Spain Drug Eluting Device Market, By Application
6.8.7.2 Spain Drug Eluting Device Market, By Product Type
6.8.7.3 Spain Drug Eluting Device Market, By Coating Type
6.8.8 Turkey Drug Eluting Device Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.8.1 Turkey Drug Eluting Device Market, By Application
6.8.8.2 Turkey Drug Eluting Device Market, By Product Type
6.8.8.3 Turkey Drug Eluting Device Market, By Coating Type
6.8.9 Rest of Europe Drug Eluting Device Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.9.1 Rest of Europe Drug Eluting Device Market, By Application
6.8.9.2 Rest of Europe Drug Eluting Device Market, By Product Type
6.8.9.3 Rest of Europe Drug Eluting Device Market, By Coating Type
7. Asia Pacific Drug Eluting Device Market: Historic and Forecast
7.1 Asia Pacific Drug Eluting Device Market: Snapshot
7.2 Asia Pacific Drug Eluting Device Market: Market Size and CAGR, By Value, 2020-2030 (USD Million & CAGR)
7.3 Asia Pacific Drug Eluting Device Market: Key Factors
7.4 Asia Pacific Drug Eluting Device Market: Segment Analysis
7.5 Asia Pacific Drug Eluting Device Market Segmentation: By Application
7.5.1 Asia Pacific Drug Eluting Device Market, By Application Overview
7.5.2 Asia Pacific Drug Eluting Device Market Size, By Cardiovascular Diseases, By Value, 2020H-2030F (USD Million & CAGR)
7.5.3 Asia Pacific Drug Eluting Device Market Size, By Peripheral Vascular Diseases, By Value, 2020H-2030F (USD Million & CAGR)
7.5.4 Asia Pacific Drug Eluting Device Market Size, By Oncology, By Value, 2020H-2030F (USD Million & CAGR)
7.5.5 Asia Pacific Drug Eluting Device Market Size, By Ophthalmology, By Value, 2020H-2030F (USD Million & CAGR)
7.5.6 Asia Pacific Drug Eluting Device Market Size, By Other Applications, By Value, 2020H-2030F (USD Million & CAGR)
7.6 Asia Pacific Drug Eluting Device Market Segmentation: By Product Type
7.6.1 Asia Pacific Drug Eluting Device Market, By Product Type Overview
7.6.2 Asia Pacific Drug Eluting Device Market Size, By Coronary Drug Eluting Stents , By Value, 2020H-2030F (USD Million & CAGR)
7.6.3 Asia Pacific Drug Eluting Device Market Size, By Peripheral Drug Eluting Stents, By Value, 2020H-2030F (USD Million & CAGR)
7.6.4 Asia Pacific Drug Eluting Device Market Size, By Drug Eluting Balloons, By Value, 2020H-2030F (USD Million & CAGR)
7.6.5 Asia Pacific Drug Eluting Device Market Size, By Drug Eluting Implants, By Value, 2020H-2030F (USD Million & CAGR)
7.7 Asia Pacific Drug Eluting Device Market Segmentation: By Coating Type
7.7.1 Asia Pacific Drug Eluting Device Market, By Coating Type Overview
7.7.2 Asia Pacific Drug Eluting Device Market Size, By Polymer Based , By Value, 2020H-2030F (USD Million & CAGR)
7.7.3 Asia Pacific Drug Eluting Device Market Size, By Non-Polymer Based, By Value, 2020H-2030F (USD Million & CAGR)
7.8 Asia Pacific Drug Eluting Device Market Segmentation: By Country
7.8.1 Asia Pacific Drug Eluting Device Market, by Country Overview
7.8.2 China Drug Eluting Device Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.2.1 China Drug Eluting Device Market, By Application
7.8.2.2 China Drug Eluting Device Market, By Product Type
7.8.2.3 China Drug Eluting Device Market, By Coating Type
7.8.3 India Drug Eluting Device Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.3.1 India Drug Eluting Device Market, By Application
7.8.3.2 India Drug Eluting Device Market, By Product Type
7.8.3.3 India Drug Eluting Device Market, By Coating Type
7.8.4 South Korea Drug Eluting Device Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.4.1 South Korea Drug Eluting Device Market, By Application
7.8.4.2 South Korea Drug Eluting Device Market, By Product Type
7.8.4.3 South Korea Drug Eluting Device Market, By Coating Type
7.8.5 Japan Korea Drug Eluting Device Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.5.1 Japan Drug Eluting Device Market, By Application
7.8.5.2 Japan Drug Eluting Device Market, By Product Type
7.8.5.3 Japan Drug Eluting Device Market, By Coating Type
7.8.6 Singapore Drug Eluting Device Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.6.1 Singapore Drug Eluting Device Market, By Application
7.8.6.2 Singapore Drug Eluting Device Market, By Product Type
7.8.6.3 Singapore Drug Eluting Device Market, By Coating Type
7.8.7 Indonesia Drug Eluting Device Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.7.1 Indonesia Drug Eluting Device Market, By Application
7.8.7.2 Indonesia Drug Eluting Device Market, By Product Type
7.8.7.3 Indonesia Drug Eluting Device Market, By Coating Type
7.8.8 Rest of Asia Pacific Drug Eluting Device Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.8.1 Rest of Asia Pacific Drug Eluting Device Market, By Application
7.8.8.2 Rest of Asia Pacific Drug Eluting Device Market, By Product Type
7.8.8.3 Rest of Asia Pacific Drug Eluting Device Market, By Coating Type
8. Middle East & Africa Drug Eluting Device Market: Historic and Forecast
8.1 Middle East & Africa Drug Eluting Device Market: Snapshot
8.2 Middle East & Africa Drug Eluting Device Market: Market Size and CAGR, By Value, 2020-2030 (USD Million & CAGR)
8.3 Middle East & Africa Drug Eluting Device Market: Key Factors
8.4 Middle East and Africa Drug Eluting Device Market: Segment Analysis
8.5 Middle East & Africa Drug Eluting Device Market Segmentation: By Application
8.5.1 Middle East & Africa Drug Eluting Device Market, By Application Overview
8.5.2 Middle East & Africa Drug Eluting Device Market Size, By Cardiovascular Diseases, By Value, 2020H-2030F (USD Million & CAGR)
8.5.3 Middle East & Africa Drug Eluting Device Market Size, By Peripheral Vascular Diseases, By Value, 2020H-2030F (USD Million & CAGR)
8.5.4 Middle East & Africa Drug Eluting Device Market Size, By Oncology, By Value, 2020H-2030F (USD Million & CAGR)
8.5.5 Middle East & Africa Drug Eluting Device Market Size, By Ophthalmology, By Value, 2020H-2030F (USD Million & CAGR)
8.5.6 Middle East & Africa Drug Eluting Device Market Size, By Other Applications, By Value, 2020H-2030F (USD Million & CAGR)
8.6 Middle East & Africa Drug Eluting Device Market Segmentation: By Product Type
8.6.1 Middle East & Africa Drug Eluting Device Market, By Product Type Overview
8.6.2 Middle East & Africa Drug Eluting Device Market Size, By Coronary Drug Eluting Stents , By Value, 2020H-2030F (USD Million & CAGR)
8.6.3 Middle East & Africa Drug Eluting Device Market Size, By Peripheral Drug Eluting Stents, By Value, 2020H-2030F (USD Million & CAGR)
8.6.4 Middle East & Africa Drug Eluting Device Market Size, By Drug Eluting Balloons, By Value, 2020H-2030F (USD Million & CAGR)
8.6.5 Middle East & Africa Drug Eluting Device Market Size, By Drug Eluting Implants, By Value, 2020H-2030F (USD Million & CAGR)
8.7 Middle East & Africa Drug Eluting Device Market Segmentation: By Coating Type
8.7.1 Middle East & Africa Drug Eluting Device Market, By Coating Type Overview
8.7.2 Middle East & Africa Drug Eluting Device Market Size, By Polymer Based , By Value, 2020H-2030F (USD Million & CAGR)
8.7.3 Middle East & Africa Drug Eluting Device Market Size, By Non-Polymer Based, By Value, 2020H-2030F (USD Million & CAGR)
8.8 Middle East & Africa Drug Eluting Device Market Segmentation: By Country
8.8.1 Middle East & Africa Drug Eluting Device Market, by Country Overview
8.8.2 GCC Drug Eluting Device Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
8.8.2.1 GCC Drug Eluting Device Market, By Application
8.8.2.2 GCC Drug Eluting Device Market, By Product Type
8.8.2.3 GCC Drug Eluting Device Market, By Coating Type
8.8.3 Israel Drug Eluting Device Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
8.8.3.1 Israel Drug Eluting Device Market, By Application
8.8.3.2 Israel Drug Eluting Device Market, By Product Type
8.8.3.3 Israel Drug Eluting Device Market, By Coating Type
8.8.4 South Africa Drug Eluting Device Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
8.8.4.1 South Africa Drug Eluting Device Market, By Application
8.8.4.2 South Africa Drug Eluting Device Market, By Product Type
8.8.4.3 South Africa Drug Eluting Device Market, By Coating Type
8.8.5 Rest of Middle East and Africa Drug Eluting Device Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
8.8.5.1 Rest of Middle East and Africa Drug Eluting Device Market, By Application
8.8.5.2 Rest of Middle East and Africa Drug Eluting Device Market, By Product Type
8.8.5.3 Rest of Middle East and Africa Drug Eluting Device Market, By Coating Type
9. Market Dynamics
9.1 Impact assessment of Market Dynamics on Drug Eluting Device Market
9.2 Drivers
9.3 Restraints
9.4 Trends
10. Ecosystem Analysis
10.1 Porter Analysis
11. Competitive Positioning
11.1 Companies’ Competitive Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of Drug Eluting Device Market
11.4 Company Profiles
11.4.1. Terumo
11.4.2. Becton, Dickinson and Company
11.4.3. Orbus Neich
11.4.4. Biotronik SE
11.4.5. Philips Group
11.4.6. Medtronic Plc
11.4.7. Lepu Medical
11.4.8. Abbott Laboratories
11.4.9. Cordis Corp
11.4.10. Boston Scientific Group
11.4.11. Other Leading Companies
12. About the Publisher & Disclaimer

Companies Mentioned

Some of the key companies profiled in this Drug Eluting Device Market include:
  • Terumo
  • Becton, Dickinson and Company
  • Orbus Neich
  • Biotronik SE
  • Philips Group
  • Medtronic Plc
  • Lepu Medical
  • Abbott Laboratories
  • Cordis Corp
  • Boston Scientific Group

Related Topics

Related Reports

Non-Drug Eluting Device Market: Market Size, Trends, Opportunities and Forecast by Application, Material Type, End-User, Region, By Country: 2020-2030 - Product Image

Non-Drug Eluting Device Market: Market Size, Trends, Opportunities and Forecast by Application, Material Type, End-User, Region, By Country: 2020-2030

  • Report
  • 298 Pages
  • Global
From
Drug Eluting Stents - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Drug Eluting Stents - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Drug Eluting Stent Market Size, Share & Trends Analysis Report By Coating Type (Polymer-based Coatings (Non-biodegradable, Biodegradable)), Polymer-free Coatings, By Application, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Drug Eluting Stent Market Size, Share & Trends Analysis Report By Coating Type (Polymer-based Coatings (Non-biodegradable, Biodegradable)), Polymer-free Coatings, By Application, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 100 Pages
  • Global
From
Drug Eluting Balloon Market by Type, Coating Technology, End User - Global Forecast 2025-2030 - Product Image

Drug Eluting Balloon Market by Type, Coating Technology, End User - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Europe Drug Eluting Stent Market Size, Share & Industry Trends Analysis Report By Application (Coronary Artery Disease, and Peripheral Artery Disease), By Coating Type, By Country and Growth Forecast, 2023 - 2030 - Product Image

Europe Drug Eluting Stent Market Size, Share & Industry Trends Analysis Report By Application (Coronary Artery Disease, and Peripheral Artery Disease), By Coating Type, By Country and Growth Forecast, 2023 - 2030

  • Report
  • 149 Pages
  • Europe
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.